• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Xyrem (sodium oxybate) Information

Xyrem (sodium oxybate) is approved to reduce attacks of muscle weakness (cataplexy) and treat daytime sleepiness in patients with narcolepsy.  

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program.


Regulatory History and Labeling from Drugs@FDA